ARTICLE | Management Tracks
Lopes-Fernandes to lead BD for Ipsen; plus Repertoire, Nicox, Inivata, Decibel, PCORI
September 25, 2020 10:50 PM UTC
Philippe Lopes-Fernandes will join Ipsen Group (Euronext:IPN; Pink:IPSEY) in its Cambridge, Mass., office as EVP and CBO on Oct. 1. Before joining Ipsen, Philippe was SVP, global head of BD and alliance management at Merck KGaA (Xetra:MRK).
Flagship Pioneering portfolio company Repertoire Immune Medicines Inc. hired Anthony Coyle as president of R&D. Repertoire aims to identify which TCRs and antigens matter in disease and apply those insights to biomarkers and therapies (see Emerging Company Profile: “Both Sides of the TCR-antigen Coin”)...